Related Experiment Video
Updated: Mar 26, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
High-density lipoprotein (HDL)/apolipoprotein A-I (ApoA-I) complex reduces von Willebrand factor (VWF) fiber length and thickness. This finding offers potential new treatments for thrombotic disorders by modulating VWF self-association.
Area of Science:
- Hematology
- Cardiovascular Biology
- Biochemistry
Background:
- Von Willebrand factor (VWF) is crucial for hemostasis and thrombosis.
- VWF self-association under shear stress contributes to arterial thrombosis.
- High-density lipoprotein (HDL) and apolipoprotein A-I (ApoA-I) are key regulators of lipid metabolism and possess anti-inflammatory properties.
Purpose of the Study:
- To investigate the effect of HDL/ApoA-I complex on VWF self-association under shear stress.
- To explore the potential anti-thrombotic mechanisms of HDL/ApoA-I.
Main Methods:
- In vitro studies using purified VWF and HDL/ApoA-I complex.
- In vivo animal models to assess VWF fiber formation and thrombosis.
- Analysis of VWF fiber length and thickness under varying shear conditions.
Main Results:
- HDL/ApoA-I complex significantly reduces the length and thickness of VWF fibers formed under shear stress.
- Demonstrated anti-adhesive and anti-thrombotic properties of HDL/ApoA-I in modulating VWF.
- Evidence of VWF modulation in both in vitro and animal models.
Conclusions:
- HDL/ApoA-I complex possesses potent anti-thrombotic effects by inhibiting VWF self-association.
- These findings link microvascular and large vessel pathologies, suggesting novel therapeutic strategies for atherosclerosis and arterial thrombosis.
- Modulation of VWF by HDL/ApoA-I represents a promising target for treating thrombotic disorders.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Regulation of Angiogenesis and Blood Supply

